Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 25, 2022 - Issue 9
433
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Non-specific effect of omega-3 fatty acid supplementation on autistic spectrum disorder: systematic review and meta-analysis

, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Karhu E, Zukerman R, Eshraghi RS, Mittal J, Deth RC, Castejon AM, et al. Nutritional interventions for autism spectrum disorder. Nutr Rev. 2020 Jul 1;78(7):515–531. doi: 10.1093/nutrit/nuz092.
  • Masi A, DeMayo MM, Glozier N, Guastella AJ. An overview of autism spectrum disorder, heterogeneity and treatment options. Neurosci Bull. 2017 Apr;33(2):183–193. doi: 10.1007/s12264-017-0100-y.
  • Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health outcomes. BioFactors. 2009;35(3):266–72.
  • Rimm EB, Appel LJ, Chiuve SE, Djoussé L, Engler MB, Kris-Etherton PM, et al. Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: A Science advisory from the American heart association. Circulation. 2018 Jul 3;138(1):e35–e47. doi: 10.1161/CIR.0000000000000574.
  • Alfawaz H, Al-Onazi M, Bukhari SI, Binobead M, Othman N, Algahtani N, et al. The independent and combined effects of omega-3 and vitamin B12 in ameliorating propionic acid induced biochemical features in juvenile rats as rodent model of autism. J Mol Neurosci. 2018 Nov;66(3):403–413. doi: 10.1007/s12031-018-1186-z.
  • Brigandi SA, Shao H, Qian SY, Shen Y, Wu B-L, Kang JX. Autistic children exhibit decreased levels of essential fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061–76. doi: 10.3390/ijms160510061.
  • Vancassel S, Durand G, Barthélémy C, Lejeune B, Martineau J, Guilloteau D, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids. 2001 Jul;65(1):1–7. doi: 10.1054/plef.2001.0281.
  • Mostafa GA, Al-Ayadhi LY. Reduced levels of plasma polyunsaturated fatty acids and serum carnitine in autistic children: relation to gastrointestinal manifestations. Behav Brain Funct. 2015 Feb 7;11:4. doi: 10.1186/s12993-014-0048-2.
  • Martins MB, Piotto RF, Barbosa M, Suaiden AS. Properties of omega-3 polyunsaturated fatty acids obtained of fish oil and flaxseed oil. Rev Inst Ciênc Saúde . 2008;26(2):153–6.
  • McNamara RK, Able J, Jandacek R, Rider T, Tso P, Eliassen JC, et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr. 2010 Apr;91(4):1060–7. doi: 10.3945/ajcn.2009.28549.
  • Witte AV, Kerti L, Hermannstädter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, et al. Impact of omega-3 fatty acid supplementation on memory functions in healthy older adults. J Alzheimers Dis. 2016;51(3):713–25. doi: 10.3233/JAD-150886.
  • Pu H, Guo Y, Zhang W, Huang L, Wang G, Liou AK, et al. Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury. J Cereb Blood Flow Metab. 2013 Sep;33(9):1474–84. doi: 10.1038/jcbfm.2013.108.
  • Agostoni C, Nobile M, Ciappolino V, Delvecchio G, Tesei A, Turolo S, et al. The role of omega-3 fatty acids in Developmental psychopathology: A systematic review on Early psychosis, autism, and ADHD. Int J Mol Sci. 2017;18(12):2608. doi:10.3390/ijms18122608
  • Horvath A, Łukasik J, Szajewska H. ω-3 fatty acid supplementation does Not affect autism spectrum disorder in children: A systematic review and meta-analysis. J Nutr. 2017 Mar;147(3):367–376. doi: 10.3945/jn.116.242354.
  • Cheng Y-S, Tseng P-T, Chen Y-W, Stubbs B, Yang W-C, Chen T-Y, et al. Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat. 2017 Oct 4;13:2531–2543. doi: 10.2147/NDT.S147305.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, Group PRISMA. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015 Jun 2;162(11):777–84. doi: 10.7326/M14-2385.
  • Higgins JP, Altman DG, Gøtzsche PC, et al. Cochrane statistical Methods grou Higgins JPT, Altman DG, Gøtzsche PC, jüni P, Moher D, oxman AD, et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.
  • Aman MG, Singh NN, Turbott SH. Reliability of the Aberrant Behavior Checklist and the effect of variations in instructions. Am J Ment Defic. 1987 Sep;92(2):237–40.
  • Reynolds CR, Kamphaus RW, Vannest KJ. Behavior Assessment System for Children (BASC) BT - encyclopedia of clinical neuropsychology. In: Kreutzer JS, DeLuca J, Caplan B, New York, NY: Springer New York; 2011. p. 366–71. doi:10.1007/978-0-387-79948-3_1524
  • Chan W, Smith LE, Hong J, Greenberg JS, Mailick MR. Validating the social responsiveness scale for adults with autism. Autism Res. 2017 Oct;10(10):1663–1671. doi: 10.1002/aur.1813.
  • Egger M, Davey Smith G, Schneider M, Minder C, Egger M, Davey Smith G, Schneider M. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997 Sep 13;315(7109):629–34. doi: 10.1136/bmj.315.7109.629.
  • Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Handbook. 2019.
  • Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study. Biol Psychiatry. 2007 Feb 15;61(4):551–3. doi: 10.1016/j.biopsych.2006.05.007.
  • Politi P, Cena H, Comelli M, Marrone G, Allegri C, Emanuele E, et al. Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study. Arch Med Res. 2008 Oct;39(7):682–5. doi: 10.1016/j.arcmed.2008.06.005.
  • Parellada M, Llorente C, Calvo R, Gutierrez S, Lázaro L, Graell M, et al. Randomized trial of omega-3 for autism spectrum disorders: effect on cell membrane composition and behavior. Eur Neuropsychopharmacol. 2017 Dec;27(12):1319–1330. doi: 10.1016/j.euroneuro.2017.08.426.
  • Keim SA, Gracious B, Boone KM, Klebanoff MA, Rogers LK, Rausch J, et al. ω-3 and ω-6 fatty acid supplementation May Reduce autism symptoms based on parent report in preterm toddlers. J Nutr. 2018;148(2):227–235. doi: 10.1093/jn/nxx047.
  • Mazahery H, Conlon CA, Beck KL, Mugridge O, Kruger MC, Stonehouse W, et al. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder. J Steroid Biochem Mol Biol. 2019;187:9–16. doi: 10.1016/j.jsbmb.2018.10.017.
  • Meiri G, Bichovsky Y, Belmaker RH. Omega 3 fatty acid treatment in autism. J Child Adolesc Psychopharmacol. 2009;19(4):449–51. doi: 10.1089/cap.2008.0123.
  • Bent S, Bertoglio K, Ashwood P, Bostrom A, Hendren RL. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord. 2011;41(5):545–54. doi: 10.1007/s10803-010-1078-8.
  • Yui K, Koshiba M, Nakamura S, Kobayashi Y. Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial. J Clin Psychopharmacol. 2012 Apr;32(2):200–6. doi: 10.1097/JCP.0b013e3182485791.
  • Bent S, Hendren RL, Zandi T, Law K, Choi JE, Widjaja F, et al. Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry. 2014 Jun;53(6):658–66. doi: 10.1016/j.jaac.2014.01.018.
  • Voigt RG, Mellon MW, Katusic SK, Weaver AL, Matern D, Mellon B, et al. Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):715–22. doi: 10.1097/MPG.0000000000000260.
  • Yui K, Imataka G, Kawasak Y, Yamada H. Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders. Life Sci. 2016;15(145):205–12. doi: 10.1016/j.lfs.2015.12.039.
  • Ooi YP, Weng SJ, Jang LY, Low L, Seah J, Teo S, et al. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore. Eur J Clin Nutr. 2015;69(8):969–71. doi: 10.1038/ejcn.2015.28.
  • Mankad D, Dupuis A, Smile S, Roberts W, Brian J, Lui T, et al. A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism. Mol Autism. 2015;21(6):18. doi: 10.1186/s13229-015-0010-7.
  • Parellada M, Llorente C, Calvo R, Gutierrez S, Lázaro L, Graell M, et al. Randomized trial of omega-3 for autism spectrum disorders: effect on cell membrane composition and behavior. Eur Neuropsychopharmacol. 2017 Dec;27(12):1319–1330. doi: 10.1016/j.euroneuro.2017.08.426.
  • Amminger GP, Berger GE, Schafer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry. 2007 Feb 15;61(4):551–3. . doi: 10.1016/j.biopsych.2006.05.007.
  • Boone KM, Gracious B, Klebanoff MA, Rogers LK, Rausch J, Coury DL, et al. Omega-3 and -6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: A randomized controlled trial. Early Hum Dev. 2017;115:64–70. doi: 10.1016/j.earlhumdev.2017.09.015.
  • Mazahery H, Conlon C, Beck KL, Kruger MC, Stonehouse W, Camargo CA, et al. Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial. Trials. 2016 Jun 23;17(1):295. doi: 10.1186/s13063-016-1428-8.
  • World Health Organization. Autism spectrum disorders [Internet]. [cited 2020 Jun 18]. Available from: https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders.
  • Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, et al. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 2011 Dec 12;11:111. doi: 10.1186/1471-2431-11-111.
  • Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, et al. Comprehensive nutritional and Dietary intervention for autism spectrum disorder-A randomized, controlled 12-month trial. Nutrients. 2018 Mar 17;10(3):369, doi: 10.3390/nu10030369.
  • Levant B, Radel JD, Carlson SE. Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in N-3 polyunsaturated fatty acids. Biol Psychiatry. 2006;1:60, (9):987-90. doi: 10.1016/j.biopsych.2005.12.013.
  • Bengmark S. Gut microbiota, immune development and function. Pharmacol Res. 2013 Mar;69(1):87–113. doi: 10.1016/j.phrs.2012.09.002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.